BIRCHBIOMED & Design

Trademark usage description

pharmaceuticals and cosmetics for fibrosis and related skin disorders, scarring (including hypertrophic and keloidal scars), burns, atrophic acne, wri Read More

Vienna Information

5 . 3 . 11

Other leavesAutres feuilles

5 . 3 . 13

Stylized leavesFeuilles stylisées

5 . 3 . 14

One leafUne feuille

15 . 9 . 1

Electrical equipmentMatériel électrique

15 . 9 . 18

Integrated circuits, computer chips Note: Including memory chips and cardsCircuits intégrés, puces électroniques Note: Y compris les puces et les cartes mémoire

26 . 4 . 2

RectanglesRectangles

26 . 4 . 15

Quadrilaterals containing representations of animals or parts of animals' bodies or plantsQuadrilatères contenant la représentation d'animaux, de parties du corps d'un animal ou de végétaux

26 . 4 . 18

Quadrilaterals containing one or more lettersQuadrilatères contenant une ou plusieurs lettres

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

Classification Information

Class [005]
Pharmaceuticals and cosmetics for fibrosis and related skin disorders, scarring (including hypertrophic and keloidal scars), burns, atrophic acne, wrinkles & rhytids, certain autoimmune diseases (including Type 1 Diabetes and Alopecia Areata), and for organ fibrosis (lungs, kidneys and liver); pharmaceutical and cosmetic preparations for fibrosis and related skin disorders, scarring (including hypertrophic and keloidal scars), burns, atrophic acne, certain autoimmune diseases (including Type 1 Diabetes and Alopecia Areata), wrinkles & rhytids, and for organ fibrosis (lungs, kidneys and liver).

Classification kind code

Class [036]
Arranging for funding for medical research and medical product and drug development services in the area of treatments for fibrosis and related skin disorders, scarring (including hypertrophic and keloidal scars), burns, atrophic acne, wrinkles & rhytids, certain autoimmune diseases (including Type 1 Diabetes and Alopecia Areata), and for organ fibrosis (lungs, kidneys and liver); awarding grants for medical research and medical product and drug development services in the area of treatments for fibrosis and related skin disorders, scarring (including hypertrophic and keloidal scars), burns, atrophic acne, certain autoimmune diseases (including Type 1 Diabetes and Alopecia Areata), wrinkles & rhytids, and for organ fibrosis (lungs, kidneys and liver); financial investment in the field of medical research and medical product and drug development services in the area of treatments for fibrosis and related skin disorders, scarring (including hypertrophic and keloidal scars), burns, atrophic acne, certain autoimmune diseases (including Type 1 Diabetes and Alopecia Areata), wrinkles & rhytids, and for organ fibrosis (lungs, kidneys and liver).

Classification kind code

Class [042]
Biomedical research services in the area of treatments for fibrosis and related skin disorders, scarring (including hypertrophic and keloidal scars), burns, atrophic acne, certain autoimmune diseases (including Type 1 Diabetes and Alopecia Areata), wrinkles & rhytids, and for organ fibrosis (lungs, kidneys and liver); research and development of new products for medicinal and cosmetic use for others in the area of fibrosis and related skin disorders, scarring (including hypertrophic and keloidal scars), burns, atrophic acne, certain autoimmune diseases (including Type 1 Diabetes and Alopecia Areata), wrinkles & rhytids, and for organ fibrosis (lungs, kidneys and liver); development and testing of pharmaceutical and cosmetic products and drug/cosmetic delivery technology in the area of fibrosis and related skin disorders, scarring (including hypertrophic and keloidal scars), burns, atrophic acne, certain autoimmune diseases (including Type 1 Diabetes and Alopecia Areata), wrinkles & rhytids, and for organ fibrosis (lungs, kidneys and liver); consulting services in the fields of scientific biotechnological research, pharmaceutical research and development, laboratory testing of materials, and pharmacogenetics in the area of fibrosis and related skin disorders, scarring (including hypertrophic and keloidal scars), burns, atrophic acne, certain autoimmune diseases (including Type 1 Diabetes and Alopecia Areata), wrinkles & rhytids, and for organ fibrosis (lungs, kidneys and liver); pharmaceutical drug development in the area of treatments for fibrosis and related skin disorders, scarring (including hypertrophic and keloidal scars), burns, atrophic acne, certain autoimmune diseases (including Type 1 Diabetes and Alopecia Areata), wrinkles & rhytids, and for organ fibrosis (lungs, kidneys and liver); drug development services in the fields of drug dosage and drug dosage form, drug delivery technologies, drug analytical methods, drug manufacturing, drug packaging, drug labeling, and drug stability, storage and testing, all in the area of treatments for fibrosis and related skin disorders, scarring (including hypertrophic and keloidal scars), burns, atrophic acne, certain autoimmune diseases (including Type 1 Diabetes and Alopecia Areata), wrinkles & rhytids, and for organ fibrosis (lungs, kidneys and liver).

Classification kind code

Class [044]
Consulting services in the field of medical and cosmetic treatment, research and diagnostic services in the area of treatments for fibrosis and related skin disorders, scarring (including hypertrophic and keloidal scars), burns, atrophic acne, certain autoimmune diseases (including Type 1 Diabetes and Alopecia Areata), wrinkles & rhytids, and for organ fibrosis (lungs, kidneys and liver).

Classification kind code

Mark Details

Serial Number

2372591

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 287 on 16^th Jan 2025	Pre-Assessment Letter Sent
Submitted for opposition 30 on 2^th Jan 2025	Filed
Submitted for opposition 1 on 2^th Jan 2025	Created
Submitted for opposition 31 on 2^th Jan 2025	Formalized